Login / Signup

Characterization of adherence and persistence profile in a real-life population of patients treated with adalimumab.

Omer GendelmanDahlia WeitzmanVered RosenbergVarda ShalevGabriel ChodickHoward Amital
Published in: British journal of clinical pharmacology (2018)
Our results indicate encouraging persistence and adherence with adalimumab of patients with inflammatory conditions.
Keyphrases
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • hidradenitis suppurativa
  • ulcerative colitis
  • glycemic control
  • oxidative stress
  • type diabetes
  • adipose tissue
  • skeletal muscle
  • weight loss